Abstract
We present three cases fulfilling diagnostic criteria of hemorrhagic variants of acute disseminated encephalomyelitis (acute hemorrhagic encephalomyelitis, AHEM) occurring within 9 days after the first shot of ChAdOx1 nCoV-19. AHEM was diagnosed using magnetic resonance imaging, cerebrospinal fluid analysis and brain biopsy in one case. The close temporal association with the vaccination, the immune-related nature of the disease as well as the lack of other canonical precipitating factors suggested that AHEM was a vaccine-related adverse effect. We believe that AHEM might reflect a novel COVID-19 vaccine-related adverse event for which physicians should be vigilant and sensitized.
| Original language | English |
|---|---|
| Article number | 820049 |
| Journal | Frontiers in Neurology |
| Volume | 12 |
| DOIs | |
| State | Published - 2 Feb 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- COVID-19
- ChAdOx1 nCoV-19
- Weston-Hurst syndrome
- acute disseminated encephalomyelitis
- acute hemorrhagic encephalomyelitis
- acute hemorrhagic leukoencephalitis
- vaccination
Fingerprint
Dive into the research topics of 'Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver